BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring

BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring

An effortless patient experience combined with actionable clinical intelligence to bring medical-grade care to the home BioIntelliSense, Inc., a…

WINFertility Launches Enhanced Digital User Experience with New Mobile App Designed to Deliver Seamless Clinical Advocacy, Improved Outcomes and Lower Costs

WINFertility Launches Enhanced Digital User Experience with New Mobile App Designed to Deliver Seamless Clinical Advocacy, Improved Outcomes and Lower Costs

Virtual Nurse Consultations with Fertility Nurse Care Managers, Personalized Benefits Center, Robust Fertility Education Content and Enhanced Digital Fertility…